This document outlines a plan to eliminate cervical cancer as a public health problem in the state of Mizoram, India by 2040. It discusses conducting HPV vaccination drives for girls, integrating screening and treatment into primary healthcare, promoting health education, and strengthening collaboration between health services. The objectives are to prevent cervical cancer through vaccination and screening, promote healthy behaviors, and enhance health services. Expected outcomes include high vaccination and screening rates, increased diagnostic capabilities, and improved access to treatment. Required resources include health educators, community workers, and expanded medical infrastructure.
On 4 March 2022, International Human Papilloma Virus (HPV) Day, the Cancer Association of South Africa (CANSA) supports the International Papillomavirus Society’s (IPVS) #OneLessWorry campaign, that aims to raise awareness of the virus, and the tools to overcome it, such as screening and vaccination programmes. HPV can cause cancer and is responsible for almost half a million deaths globally each year.
#OneLessWorry #HPV #EliminateCervicalCancer #CANSACervicalCancerAwareness
Find out more:
https://cansa.org.za/cervical-cancer/
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...IIJSRJournal
Background: Human papillomavirus is the main factor in the etiology of cervical cancer, with over 99.7% of cases being associated with high-risk human papillomavirus infection. Although the majority of HPV infections are asymptomatic and self-limiting, persistent HPV infection can result in genital warts, oropharyngeal cancer, and cervical cancer in women, in addition to various anogenital malignancies and other genital warts in both men and women.
Method: This was a cross-sectional descriptive study which employed a convenience sampling technique where both qualitative and quantitative methods were used for data collection. A total of 374 participants were enrolled in the study and a semi structured questionnaire was administered to collect socio-demographic, reproductive and sexual history data. Laboratory analysis involved detection of HPV DNA hybrids with a chemiluminescent substrate, Digene Hybrid Capture 2 technology. Descriptive and inferential (logistic regression) analyses at level of significant (α=0.05) were used to summarize the data, and results illustrated using charts and tables.
Results: The study findings reported a significant risk level of human papillomavirus among female of age group 40-49 years (AOR; 0.15, 95% CI: 0.03-0.79; p = 0.026). Furthermore, in bivariate logistic regression the circulating HPV genotypes among the respondents was significantly characterized among women of the same age group (95% CI; 0.09-0.7; p = 0.008) as well as in the multivariate regression (AOR = 0.13; 95% CI: 0.02-0.72; p = 0.019).
Conclusion: The study thus concluded that there is 23/94 (25.67%) risk of developing cervical cancer due to high risk level HPV (with the presence of low risk level HPV 71/94 (74.33%) known for causing various forms of warts. Therefore, there is need for combined efforts from the Ministry of health and stakeholders to avail and train health care workers on the usage of HPV DNA kits to ensure timely detection of low and high-risk levels HPV. This will ensure timely identification of women at increased risk for the development of cervical cancer, thereby reducing mortality rate.
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain Lifecare Centre
Cervical Cancer In India: A Preventable Tragedy That Requires Urgent Attention
It is estimated that in India, about 160 million women aged 30-59 years are at risk of developing cervical cancer, with fatality rate of 50 per cent
On 4 March 2022, International Human Papilloma Virus (HPV) Day, the Cancer Association of South Africa (CANSA) supports the International Papillomavirus Society’s (IPVS) #OneLessWorry campaign, that aims to raise awareness of the virus, and the tools to overcome it, such as screening and vaccination programmes. HPV can cause cancer and is responsible for almost half a million deaths globally each year.
#OneLessWorry #HPV #EliminateCervicalCancer #CANSACervicalCancerAwareness
Find out more:
https://cansa.org.za/cervical-cancer/
Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Pa...IIJSRJournal
Background: Human papillomavirus is the main factor in the etiology of cervical cancer, with over 99.7% of cases being associated with high-risk human papillomavirus infection. Although the majority of HPV infections are asymptomatic and self-limiting, persistent HPV infection can result in genital warts, oropharyngeal cancer, and cervical cancer in women, in addition to various anogenital malignancies and other genital warts in both men and women.
Method: This was a cross-sectional descriptive study which employed a convenience sampling technique where both qualitative and quantitative methods were used for data collection. A total of 374 participants were enrolled in the study and a semi structured questionnaire was administered to collect socio-demographic, reproductive and sexual history data. Laboratory analysis involved detection of HPV DNA hybrids with a chemiluminescent substrate, Digene Hybrid Capture 2 technology. Descriptive and inferential (logistic regression) analyses at level of significant (α=0.05) were used to summarize the data, and results illustrated using charts and tables.
Results: The study findings reported a significant risk level of human papillomavirus among female of age group 40-49 years (AOR; 0.15, 95% CI: 0.03-0.79; p = 0.026). Furthermore, in bivariate logistic regression the circulating HPV genotypes among the respondents was significantly characterized among women of the same age group (95% CI; 0.09-0.7; p = 0.008) as well as in the multivariate regression (AOR = 0.13; 95% CI: 0.02-0.72; p = 0.019).
Conclusion: The study thus concluded that there is 23/94 (25.67%) risk of developing cervical cancer due to high risk level HPV (with the presence of low risk level HPV 71/94 (74.33%) known for causing various forms of warts. Therefore, there is need for combined efforts from the Ministry of health and stakeholders to avail and train health care workers on the usage of HPV DNA kits to ensure timely detection of low and high-risk levels HPV. This will ensure timely identification of women at increased risk for the development of cervical cancer, thereby reducing mortality rate.
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain Lifecare Centre
Cervical Cancer In India: A Preventable Tragedy That Requires Urgent Attention
It is estimated that in India, about 160 million women aged 30-59 years are at risk of developing cervical cancer, with fatality rate of 50 per cent
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
1. RAJAGIRI COLLEGE OF SOCIAL SCIENCES (AUTONOMOUS)
Demystifying
Cervical Cancer
TOGETHER WE CAN MAKE HISTORY, IT'S WITHIN OUR REACH
Date: FEBRUARY 28, 2022
2. WE THE TEAM
ALEENA SEBASTIAN
ANILA K S
JAISON KURIAKOSE
LIJA MARY MATHEW
NESTY PAUL
SONIYA GEORGE
TAIBAH HAIDARY
3. Learning
Agenda
What we'll discuss
this morning
What is cervical cancer
Planning Community based
interventions
Why treating it is important
Strategies to eliminate cervical
cancer
Scaling Up
4. Director- General, World Health Organisation
Dr Tedros Adhanom Ghebreyesus
“One woman dies of
cervical cancer every
two minutes…Each
one is a tragedy, and we
can prevent it.”
6. Cervical cancer is a type of cancer that
develops in a woman's cervix (the
entrance to the uterus from the vagina).
The infection with high-risk human
papillomaviruses (HPV), an exceedingly
prevalent virus spread through sexual
contact, is connected to almost all
cervical cancer cases (99 percent).
Although most HPV infections go away
on their own with no symptoms, a
persistent infection can lead to cervical
cancer in women.
7. The fourth most frequent cancer in women
is cervical cancer.
Cervical cancer was diagnosed in around
570 000 women worldwide in 2018, with
approximately 311 000 women dying from
the disease. (WHO,2019)
8. Nearly half of high-grade cervical pre-cancers are
caused by two human papillomavirus (HPV) strains (16
and 18).
HPV is mostly transmitted through sexual contact,
and the majority of persons become infected with HPV
shortly after sexual activity begins. More than 90% of
them finally recover from the virus.
Cervical cancer is six times more likely in HIV-positive
women than in HIV-negative women.
Cervical cancer can be prevented at a low cost by
vaccinating against HPV and screening and treating
pre-cancer lesions.
Cervical cancer can be cured if caught early and treated
effectively.
Primary prevention (HPV vaccine), secondary
prevention (screening and treatment of pre-cancerous
lesions), and tertiary prevention (detection and
treatment of invasive cervical cancer) and palliative
care are all part of a comprehensive cervical cancer
control strategy.
9. It takes 15 to 20 years for cervical cancer to develop in women with
normal immune systems.
It can take only 5 to 10 years in women with weakened immune
systems, such as those with untreated HIV infection
10.
11. Cervical cancer is typically not detected
until it has progressed and symptoms
appear in low- and middle-income
countries, where access to these
preventive methods is limited.
Furthermore, access to cancerous lesion
treatment (for example, cancer surgery,
radiation, and chemotherapy) may be
limited in these nations, resulting in a
greater rate of cervical cancer death.
In high-income nations, there are
programmes in place that allow
girls to be vaccinated against HPV
and women to be checked and
treated appropriately on a regular
basis. Screening identifies pre-
cancerous lesions at an early
stage, when they can be easily
treated.
12. HPV Vaccination is not included in National
Vaccination schedule.
Fewer than 1 in 10 women have been
screened for cervical cancer in the last 5
years
Crude cervical cancer incidence per 100
000 women (2020): 18.7
Mizoram is the "Cancer Capital" of the
country and it tops in the list of Cervical
Cancer Incidence.
In India,
13. Goal of the
project
“To eliminate Cervical Cancer
as a public health problem
through Prevention,
Protection and Promotion in
the state of Mizoram by
2040”.
14. Objectives
To prevent and
protect women
from the
incidence of
cervical cancer
through
vaccination,
screening and
treatment
To promote
cancer free
healthy
behaviour
through
health
education
programmes
To enhance the
provision of
formal and
informal health
services to
women in order
to reduce
cervical cancer
risks and
prevalence
To strengthen the
health services by
enhancing
coordinated
collaboration of
multisectoral
governmental
and non-
governmental
partners
15. Platforms
of Care
1.The self-care interventions are
• Following healthy behaviours which protect the
individual from cervical cancer. (Safe sexual
practices, hygienic surroundings)
• Self-motivation of the individuals to take
vaccinations and screening tests.
• HPV self-sampling kits can be used to screen.
2.Primary Health Care:
Vaccinations, Primary and early screening and referrals
can be provided through primary health care services.
This level of care platform can be utilised for awareness
generation, early prevention and protection against the
disease.
3. Specialist Health Care:
Affordable and accessible treatments like surgery,
radiotherapy, chemotherapy etc. can be done through
specialist care services
16. Conduct a massive HPV vaccination drive for girls below the age of 15
in 8 districts of Mizoram.
School-based immunization programs
Community-based outreach programs for girls who are out of
school.
Integrating screening and treatment services to primary care systems
like sexual and reproductive health services, HIV care and treatment
clinics, antenatal care, well women clinics and school-based health
outreach.
Distribution of self-screening kits among women
Increasing laboratories with high quality pathology services.
Making affordable telepathology services in integration with medical
colleges in Mizoram.
Improving surgical and radiation capacity of hospitals in Mizoram.
1.
2.
Objective 1: To prevent and protect women from the
incidence of cervical cancer through vaccination,
screening and treatment
17. Objective 2: To promote cancer free
healthy behaviour through health
education programmes
Awareness programmes in collaboration with various governmental, non-
governmental organisation in providing health literacy and other educational
initiatives, age-appropriate information on sexual and reproductive health, safer
sexual practices such as delaying sexual debut, decreasing the number of sexual
partners, condom use, and male circumcision in educational institutions and
communities.
Distribution of dissemination materials through IEC, media etc
18. Objective 3: To strengthen the health services by enhancing
coordinated collaboration of multisectoral governmental and
non-governmental partners.
Collaborate with health service delivery systems like hospitals,
labs, medical institutions to provide affordable and accessible
primary, secondary and tertiary services to people
Objective 4: To enhance the provision of formal and informal
health services to women in order to reduce cervical cancer
risks and prevalence
Connecting community health workers with individuals so that
proper health services are provided.
Conducting regular inspections and house visits by health workers
to ensure that vaccinations and screenings are done properly
19. Expecting
Outcomes
90% of girls under the age of 15 are HPV
vaccinated in Mizoram state by 2025.
80% of women are screened for high
performance VIA test for detecting cervical
cancer.
50 laboratories with sophisticated diagnosing
machines are introduced with VIA screening by
2030.
25 % Increase in number of oncology centres in
the state by 2030.
90% of women diagnosed with cervical cancer
receives treatment from affordable and
accessible health services by 2030.
20. All schools in state of Mizoram receive awareness programs on
cervical cancer.
Massive distribution of IEC materials in 8 districts of
Mizoram.
Increased number of MOUs with various health delivery
organisations.
90% of women are registered on a common database for
regular screening and diagnosis.
90% of households in Mizoram are visited by community
health workers by 2030 to promote healthy behaviours and
monitor the progress in preventing cervical cancer.
22. SCALING UP
USER ORGANISATION
ENVIRONMENT
THE INNOVATION
RESOURCE TEAM
DISSEMINATION &
ADVOCACY
COSTS/ RESOURCE MOBILISED
ORGANSATIONAL
PROCESS
MONITORING & EVALUATION
TYPES OF SCALING UP
23. Thank you!
"Through cost-effective, evidence-
based interventions, including human
papillomavirus vaccination of girls,
screening and treatment of
precancerous lesions, and improving
access to diagnosis and treatment of
invasive cancers, we can eliminate
cervical cancer as a public health
problem and make it a disease of the
past."
Dr Tedros Adhanom Ghebreyesus,
Director-General, World Health
Organization